Ontology highlight
ABSTRACT: Background
Infants and children with dominant de novo mutations in GNAO1 exhibit movement disorders, epilepsy, or both. Children with loss-of-function (LOF) mutations exhibit Epileptiform Encephalopathy 17 (EIEE17). Gain-of-function (GOF) mutations or those with normal function are found in patients with Neurodevelopmental Disorder with Involuntary Movements (NEDIM). There is no animal model with a human mutant GNAO1 allele.Objectives
Here we develop a mouse model carrying a human GNAO1 mutation (G203R) and determine whether the clinical features of patients with this GNAO1 mutation, which includes both epilepsy and movement disorder, would be evident in the mouse model.Methods
A mouse Gnao1 knock-in GOF mutation (G203R) was created by CRISPR/Cas9 methods. The resul
SUBMITTER: Feng H
PROVIDER: S-EPMC6347370 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature